Consensus Cloud Solutions, Inc. Q4 FY2024 earnings call

Management Statement and Operational Highlights

• Corporate Growth: Strong Q4 growth of approximately 7.1%, with full-year corporate revenue up 4.8%. Focus on health care sector, VA facilities rollout, and Clarity offerings.
• SoHo Performance: Revenue decline slowing, ARPA slightly improved, with focus on optimizing marketing spend.
• EBITDA and Cash Flow: Q4 EBITDA margin was 51%, full-year EBITDA margin was approximately 54%, and there was a record free cash flow of $88 million. Debt repurchases totaled $144 million in 2024.
• 2025 Outlook: Anticipate flat year-end revenues, plan to add personnel to corporate go-to-market operations, with an expected 1 percentage point impact on margin in 2025 but aiming for revenue growth in 2026.

Segment Performance

• Corporate Channel: Q4 2024 revenue was $52.9 million, up from $49.4 million in Q4 2023 (7.1% increase). Full-year corporate revenue was $209.1 million, a 4.8% year-over-year growth. Revenue contribution from corporate was significant, with strong growth in Q4 and a 4.8% full-year growth.
• SoHo Channel: Q4 2024 revenue was $34.1 million, down from $38.3 million in Q4 2023 (11.1% decrease). Full-year SoHo revenue was $141.3 million, a 13.3% year-over-year decline.

Guidance

• Full year 2025 revenue guidance: $343 million to $357 million (midpoint $350 million).
• Adjusted EBITDA guidance: $179 million to $190 million (midpoint $185 million).
• Adjusted EPS guidance: $5.03 to $5.42 (midpoint $5.22).
• Q1 2025 revenue guidance: $85 million to $89 million (midpoint $87 million).
• Adjusted EBITDA guidance: $44.8 million to $47.8 million (midpoint $46.3 million).
• Adjusted EPS guidance: $1.26 to $1.36 (midpoint $1.31).

Risks

• Uncertainties in macroeconomic and political conditions affecting corporate growth.
• Complexity in deploying advanced AI products like Clarity due to customizations needed for individual customers.
• Refinancing challenges, particularly with noncallable 6.5% notes having prohibitive costs.

Question and Answer

• Q: Talk about uptake of advanced products like Clarity and jSign. A: Johnny Hecker mentioned Clarity is in full production, uses AI to extract data from unstructured documents, has proof of concepts and some in production, focusing on replicable solutions for prior authorization and clinical document processing.
• Q: Corporate revenue growth expectations and demand environment. A: Scott Turicchi said corporate growth expected to be approximately 6.5%, with demand turning corner due to normalized market conditions and go-to-market adjustments.
• Q: 2025 go-to-market investments allocation. A: Jim Malone and Scott Turicchi discussed ramping up sales headcount, shifting marketing funds to corporate, with impact ramping from Q1 to Q4.
• Q: Why 2025 guidance not more progressive. A: Johnny Hecker explained large customers have longer sales and ramp cycles, like the VA rollout taking time.
• Q: Drivers of corporate growth range, SoHo churn, and intended uses of cash. A: Scott Turicchi said corporate growth driven by new customers, SoHo churn stable with discounted first month, cash intended for debt repayment and stock repurchases.
• Q: VA rollout impact and health care space. A: Scott Turicchi said VA rollout expected to contribute approximately $5 million in 2025, with no expected impact from federal bureaucracy disruptions on VA business.